Medicines Australia and the Generic and Biosimilars Medicines Association have shared concerns about medicine shortages that are impacting patients. 22 July 2022
Novartis has reported slightly lower than expected revenues for the second quarter, coming in at $12.78 billion dollars, a 1% decline from the same period of la 19 July 2022
Advocate General Juliane Kokott, an adviser to the Court of Justice of the European Union, has urged the court to find that a series of pay-for-delay deals agre 15 July 2022
Generics giant Teva Pharmaceutical Industries is pushing hard to make its viewpoint known as the European Commission (EC) draws up new legislation for medicines 30 June 2022
Earlier-than-expected US competition for Gilenya (fingolimod) in relapsing remitting multiple sclerosis (RRMS) could be on the way, after a patent litigation de 22 June 2022
London-headquartered generics company Hikma Pharmaceuticals has announced that its chief executive Siggi Olafsson has resigned in order to ‘pursue other opportu 26 May 2022
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.